Keywords: Body: Urogenital
This presentation will highlight the clinical challenges of the diagnostic MRI-driven pathway for prostate cancer and the role that Artificial Intelligence can play to overcome these challenges. In the current literature/clinical practice, AI is mainly used in the interpretation phase of the diagnostic pathway. In the future, AI will also play a role in other stages of this pathway; from the pre-imaging until the patient management stage.